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Mutations in the zinc finger transcription factor ZIC3 cause X-linked heterotaxy and have also been identified in
patients with isolated congenital heart disease (CHD). To determine the relative contribution of ZIC3 mutations
to both heterotaxy and isolated CHD, we screened the coding region of ZIC3 in 194 unrelated patients, including
61 patients with classic heterotaxy, 93 patients with heart defects characteristic of heterotaxy, and 11 patients with
situs inversus totalis. Five novel ZIC3 mutations in three classic heterotaxy kindreds and two sporadic CHD cases
were identified. None of these alleles was found in 97 ethnically matched control samples. On the basis of these
analyses, we conclude that the phenotypic spectrum of ZIC3 mutations should be expanded to include affected
females and CHD not typical for heterotaxy. This screening of a cohort of patients with sporadic heterotaxy
indicates that ZIC3 mutations account for ∼1% of affected individuals. Missense and nonsense mutations were
found in the highly conserved zinc finger–binding domain and in the N-terminal protein domain. Functional analysis
of all currently known ZIC3 point mutations indicates that mutations in the putative zinc finger DNA binding
domain and in the N-terminal domain result in loss of reporter gene transactivation. It is surprising that trans-
fection studies demonstrate aberrant cytoplasmic localization resulting from mutations between amino acids 253–
323 of the ZIC3 protein, indicating that the pathogenesis of a subset of ZIC3 mutations results at least in part
from failure of appropriate nuclear localization. These results further expand the phenotypic and genotypic spectrum
of ZIC3 mutations and provide initial mechanistic insight into their functional consequences.
Introduction
The failure to correctly establish left-right patterning
during embryogenesis results in the clinical phenotype
of heterotaxy. Affected patients typically have an ab-
normal arrangement of thoracic and visceral organs, and
significant morbidity and mortality result from a wide
variety of congenital defects. Complex congenital cardio-
vascular malformations (CCVM) are classically associ-
ated with heterotaxy and account for much of the clinical
severity. The incidence of heterotaxy has been difficult to
estimate, in part because birth-defect registries track the
constellation of anatomic abnormalities separately. In ad-
dition, there is no widespread agreement regarding the
minimal diagnostic criteria necessary to fulfill a diagnosis
of heterotaxy. A recent study with strict diagnostic criteria
estimates the prevalence as 1/10,000 births (Lin et al.
2000), closely approximating the findings of the Balti-
more-Washington Infant Study, in which the incidence
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of cardiac malformations associated with abnormal la-
terality is estimated at 1.44/10,000 live births (Ferencz
1997). In both studies, a male-to-female ratio of ∼2:1
was observed. Overall, this class of defects accounts for
∼3% of congenital heart disease (CHD).
Classic heterotaxy, or situs ambiguus, may include
failure of internal organs to lateralize, failure of paired
organ primordia to regress, mirror-image reversals, and/
or isomerism (Casey 1999; Aylsworth 2001). Two broad
clinical categories of heterotaxy—polysplenia and
asplenia—are typically used to classify the disorder, al-
though the spleen is not infrequently normal in position
and number in heterotaxy cases. Asplenia represents a
failure of left-sided patterning and suggests bilateral
right-sidedness. Polysplenia suggests bilateral left-sided-
ness, resulting from either a failure of the midline barrier
or a lack of right-side patterning (Peoples et al. 1983;
Phoon and Neill 1994; Ticho et al. 2000). Cardiovascular
malformations in heterotaxy with asplenia include mal-
position and transposition of the great arteries (80% of
patients), common atrium or atrial septal defects (90%
of patients), atrioventricular septal defect (80% of pa-
tients), bilateral superior vena cava (50% of patients),
pulmonary atresia and stenosis (80% of patients), single
ventricle (50% of patients), and total anomalous pul-
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monary venous connection (70% of patients) (Gutgesell
1998). Several cardiovascular malformations are partic-
ularly associated with the polysplenia-type anatomy but
are rare in asplenia, including partial anomalous pul-
monary venous return (40% of patients), intrahepatic
interruption of the inferior vena cava with connection to
the azygous or hemiazygous vein (70% of patients), and
left ventricular outflow tract obstruction (40% of pa-
tients). In addition to cardiac defects, some or all of the
abdominal organs may be aberrantly positioned. Com-
mon defects include left-sided liver, right-sided stomach,
and gut malrotation. Lung lobation may be isomeric or
reversed, indicating a failure of correct left-right speci-
fication. Although the anatomic constellation of findings
consistent with classic heterotaxy has been well doc-
umented, laterality disorders likely comprise a spectrum
of severity such that milder cases may fail to be ascer-
tained or to be properly identified as left-right patterning
defects.
Despite the difficulties associated with clinical and
epidemiological studies of heterotaxy, the genetic basis
of this disorder has been identified in a small number
of familial cases, and studies of left-right patterning in
animal models are yielding insights into the underlying
molecular pathogenesis (Mercola 1999; Burdine and
Schier 2000; Mercola and Levin 2001; Hamada et al.
2002; Bisgrove et al. 2003; Ware and Belmont 2003).
Mutations in three genes that function in the trans-
forming growth factor–b (TGFb) signaling pathway—
activin receptor type IIB (ACVR2B [MIM 602730]), an
EGF-CFC family member CRYPTIC (MIM 605194),
and LEFTYA (MIM 601877)—have been found in a
small number of patients with classic heterotaxy (Kosaki
et al. 1999a, 1999b; Bamford et al. 2000). Recently, mu-
tations in CRELD1 (MIM 607170), a cell adhesion mol-
ecule, and NKX2.5 (MIM 004387) have been associated
with heterotaxy (Watanabe et al. 2002; Robinson et al.
2003). However, only single patients with laterality de-
fects were observed in the latter studies, and the phe-
notypic consequences of gene defects in these loci there-
fore require further characterization.
The first mutations identified in patients with hetero-
taxy were in the zinc finger transcription factor ZIC3
(MIM 306955). To date, point mutations have been
described in four X-linked familial cases, in one spo-
radic case of heterotaxy, and in one case of isolated
CHD (i.e., congenital heart defect consistent with het-
erotaxy without other visceral anomalies) (Casey et al.
1993; Ferrero et al. 1997; Gebbia et al. 1997; Megar-
bane et al. 2000). These alleles include frameshift, mis-
sense, and nonsense mutations. In addition, deletion of
the ZIC3 locus has been associated with situs ambiguus,
suggesting that loss of function may underlie the path-
ogenesis in the patients with point mutations (Ferrero
et al. 1997). Female carriers in the reported familial
cases had no CHD, although females in one family had
situs inversus with anal stenosis. In addition, ZIC3 trun-
cation has been reported in one family with apparently
isolated CHD (Megarbane et al. 2000), suggesting that
an unknown proportion of isolated CHD may be caused
by mutations in ZIC3. Similarly, mutations in CRYPTIC
have recently been identified in patients with isolated
transposition of the great arteries (TGA) and double out-
let right ventricle (Goldmuntz et al. 2002). These findings
have suggested that isolated CHD may be caused by
genes involved in left-right axis development and that
there may be variable expression of mutant alleles within
and between families. It is currently unclear to what de-
gree ZIC3 mutations contribute to sporadic heterotaxy,
and this information is necessary to provide accurate
counseling information to families.
In the present study, we have undertaken screening
for ZIC3 mutations to determine the relative contri-
bution of this gene to sporadic heterotaxy and isolated
CHD. Newly identified familial cases have also been
analyzed. Novel ZIC3 mutations have been identified
and, along with previously reported mutations, their
functional significance has been confirmed by transac-
tivation and subcellular-localization assays. These re-
sults permit an expansion of the known genotypic and
phenotypic spectrum of ZIC3 mutations, provide coun-
seling information for individuals with classic hetero-
taxy (as well as those with isolated congenital heart
defects), and provide insight into the pathophysiology
of ZIC3 defects.
Patients and Methods
Patients
For the purposes of the present study we categorized
patients with laterality disorders into three subgroups:
classic heterotaxy (familial and sporadic), CHD heter-
otaxy (familial and sporadic), and situs inversus (spo-
radic). Patients with classic heterotaxy have CCVM and
evidence of disrupted left-right patterning in at least
one other organ system, including any of the following
anomalies: asplenia, polysplenia, evidence of splenic dys-
function, malrotation, omphalocele, abdominal situs in-
versus, bilateral bilobed lungs, bilateral trilobed lungs,
abnormalities of the liver or gallbladder, or stomach si-
tus. Patients were categorized as having CHD heterotaxy
if they had normal situs in other organs or if insufficient
data were available to make a determination. The types
of CCVM included in this study were based on those
described in the Baltimore-Washington Infant Study,
which included laterality and looping defects. Patients
categorized as affected by situs inversus had situs in-
versus totalis. The disorder was considered familial if a
first-degree relative had a congenital heart defect of any
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Table 1
Cardiac Manifestations of the Heterotaxy Cohort
CARDIAC
FINDINGa
CLASSIC HETEROTAXY
CHD
HETEROTAXY
(N p 93)
Asplenia
(N p 28)
Polysplenia
(N p 9)
Normal Spleen
(N p 5)
Not Determined
(N p 19)
Levocardia 7 (25%) 8 (89%) 1 10 (53%) 56 (69%)
Mesocardia 0 0 0 2 (11%) 1
Dextrocardia 13 (46%) 1 (11%) 4 6 (32%) 24 (30%)
HLHS 3 (11%) 0 0 2 (11%) 5 (6%)
PA 8 (29%) 1 (11%) 3 7 (37%) 14 (17%)
PS 13 (46%) 3 (33%) 1 3 (16%) 28 (35%)
CAVC 19 (68%) 4 (44%) 1 1 4 (5%)
DILV 1 0 0 0 3 (4%)
DORV 8 (29%) 2 (22%) 2 4 (21%) 17 (21%)
Arch abn 2 0 2 4 (21%) 6 (7%)
D-TGA 14 (50%) 3 (33%) 2 8 (42%) 28 (35%)
L-TGA 0 0 2 1 20 (25%)
TAPVR 10 (36%) 1 (11%) 1 2 (11%) 3 (4%)
PAPVR 5 (18%) 0 2 1 3 (4%)
SVC abn 14 (50%) 5 (56%) 2 4 (21%) 5 (6%)
IVC abn 9 (32%) 7 (78%) 2 2 (11%) 7 (9%)
a Abn p abnormality; CAVC p complete atrioventricular canal; DILV p double inlet left
ventricle; DORVp double outlet right ventricle; D-TGAp D-transposition of the great arteries;
HLHS p hypoplastic left heart syndrome; IVC p inferior vena cava; L-TGAp L-transposition
of the great arteries; PA p pulmonic atresia; PAPVR p partial anomalous pulmonary venous
return; PS p pulmonic stenosis; SVC p superior vena cava; TAPVR p total anomalous pul-
monary venous return.
Table 2
ZIC3 Nucleotide Changes
Pedigree Inheritance Sex Ethnicity
Nucleotide
Change
Amino Acid
Change Amplicon
LAT 107 Familial M White 1262TrA C253S 1c
LAT 129 Familial M White 1250CrT Q249X 1c
LAT 138 Familial M White 633CrA S43X 1a
JT 715 Sporadic M White 1154CrG P217A 1b
LAT 818 Sporadic F White 1718ArG K405E 2
JT 58 Sporadic M Hispanic 1417GrA; 1936CrA R304; R 3′ UTR 1c; 3
LAT 467 Sporadic F Hispanic 1366GrA V287V 1c
type or if a second- or third-degree relative had evidence
of a laterality disorder. Further details on enrollment
criteria can be obtained at the Baylor College of Med-
icine Cardiovascular Genetics Web site. Controls were
from the Baylor Polymorphism Resource, a set of lym-
phoblastoid cell lines developed from healthy adults in
which ethnic information has been retained.
Phenotypic information was established via patient
history and chart review, when available. Informed con-
sent was obtained from all individuals in accordance
with the protocol approved by the institutional review
board of Baylor College of Medicine. Blood samples
were collected from patients and parents, and Epstein-
Barr virus–transformed cell lines were established. Ge-
nomic DNA was prepared from cell lines or fibroblast
cultures (fetal samples) by standard procedures.
Mutation Detection
Exons 1–3 of the ZIC3 gene (GenBank accession num-
ber NM_008413) were amplified by PCR, using the fol-
lowing five primer sets: exon 1aF 5′ TCTTGCAGTGAC-
GGAAAGTT-3′ and exon 1aR 5′-TTCATGTTCATGG-
GGCTGTA-3′; exon 1bF 5′-GCGCACGATCTATCTT-
CAGG-3′ and exon 1bR 5′-CCGCATATAACGGAAGA-
AGG-3′; exon 1cF 5′-TACAGCCCCATGAACATGAA-3′
and exon 1cR 5′-TCTCCCTCGCGCTCTAAGT-3′; exon
2F 5′-GCTGCTTGCCTCTGAGAAAC-3′ and exon 2R
5′-ACGTGGAAGACAGTGGGTTG-3′; and exon 3F 5′-
GCTCTTGTTTTTGCTTGCAC-3′ and exon 3R 5′-CAT-
TTCCATCTGATTGGTCTCA-3′. All PCRs were per-
formed using 200 ng genomic DNA, 200 mM dNTPs,
and 20 pmol of each primer. Samples were purified using
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Figure 1 Conservation of ZIC3 sequence and location of all known mutations. The five C2H2 zinc finger domains are shaded. The amino
acid position for each mutation is boxed. Symbols above each box signify the type of mutation: circle () p missense; star () p nonsense;
downward arrowhead () p insertion.
Qiagen PCR purification and were sequenced using an
ABI 3700.
Plasmids and Mutagenesis
A 1.4-kb Kpn1-DraI fragment of the human ZIC3
cDNA, encompassing the entire ORF, was subcloned in
frame into the KpnI-NotI sites of a pHM6 expression
vector (Roche) and into the eGFP vector (Clontech), to
create an N-terminal hemagglutinin (HA)–tagged fusion
and an N-terminal GFP fusion, respectively. ZIC3 mu-
tations were introduced into the Kpn1-Dra1 fragment
via Quik-Change site-directed mutagenesis (Stratagene),
were sequenced in their entirety, and were subcloned into
pHM6.
Transcriptional Assay
HeLa cells were maintained in a-modified Eagle me-
dium with 2.5% fetal bovine serum and 7.5% newborn
calf serum. Cells were transfected using lipofectamine
(Roche) according to the manufacturer’s instructions.
Cotransfections were performed using HA-ZIC3 con-
structs and an SV40 luciferase reporter plasmid (pGL3
promoter vector; Promega); results were normalized to
a promoterless luciferase vector (pGL3 basic; Promega).
Figure 2 ZIC3 mutations in familial heterotaxy. Sequence traces for the hemizygous proband are shown below each pedigree. Sequences shown for LAT 129 and LAT 138 represent the reverse
complement. The phenotypes of affected individuals for whom data are available are shown in table 3.
Table 3
Phenotypic Characteristics of Patients with ZIC3 Mutation
PEDIGREE
ABNORMALITY IN
Atria Ventricles
Great
Vessels
Abdominal
Situs Spleen Gut Liver/Bile Duct GU Skeleton Other
107 IV-4 R atrial isomerism HLHS TGA; TAPVR Asplenia Malrotation Abnormal liver lobation Webbed neck;
bilat trilobed lungs
107 IV-1 Omphalocele Horseshoe kidney Lumbosacral spine
anomalies
Cystic hygroma
129 IV-1 Situs solitus Single ventricle;
CAVC; PS;
DORV
PDA; D-TGA;
TAPVR
Abnormal Asplenia Horseshoe kidney Low-set ears
129 III-6 Common atrium HLHS; PA;
dextro; CAVC
Bilat SVC Asplenia Tracheoesophageal
fistula
Imperforate anus;
renal dysplasia
Radial dysplasia;
vertebral defect
129 III-8 PS; DORV; VSD Abnormal IVC;
right aortic
arch
Bowel obstruction Cholelithiasis;
recurrent
cholecystitis
138 IV-4 CAVC; DORV TGA; TAPVR;
bilat SVC
Abnormal Asplenia Cholestasis
with biliary atresia
138 IV-2 ASD; situs solitus DORV; VSD; PS TGA; interrupted
IVC
Normal Normal Normal EHBA;
cholestatic liver disease
Imperforate anus Bilat club feet; fused
lumbar vertebrae
Posterior
embryotoxon;
low-set ears
138 IV-1 Club foot
818 ASD VI; VSD; PS L-TGA
15 ASD PS
NOTE.—Bilat p bilateral; EHBA p extrahepatic biliary atresia; PDA p patent ductus arteriosus. For an explanation of other abbreviations used, please see table 1, footnote a.
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Figure 3 ZIC3 mutations alter transactivation of an SV40 luciferase reporter gene. The luciferase activity of an SV40-luciferase construct
cotransfected with HA-ZIC3 wild-type (WT) or mutant constructs is indicated. The specific HA-ZIC3 construct used for cotransfection is shown
below each bar. Luciferase activities were measured relative to a promoterless control plasmid and the mean fold-activation as compared with
that of the wild type is expressed as a percentage. Each bar represents a minimum of four separate experiments. Vertical lines indicate the
standard deviation for each set of experiments.
A pRL-TK luciferase vector served as a control for trans-
fection efficiency. Cells were harvested 48 h after trans-
fection, and luciferase activities were determined using
the Dual Luciferase Reporter Assay System (Promega).
Firefly luciferase activities were normalized to Renilla
luciferase activity. All results represent a minimum of
four experiments.
Immunofluorescence and Subcellular Localization
HeLa cells were seeded onto glass coverslips at 5 #
105 cells/ml 12–18 h prior to transfection. The HA-ZIC3
expression constructs containing wild-type and mutant
ZIC3 were transfected into HeLa cells by use of Lipo-
fectamine (Roche), according to the manufacturer’s in-
structions. After 24 h, the cells were fixed in 4% para-
formaldehyde/PBS on ice for 30 min, washed three
times in PBS, and permeabilized in 0.3% Triton X/PBS
for 2 min at room temperature. After a brief wash in
0.1% Triton X/PBS, the cells were blocked in 1% BSA/
0.1% Triton X in PBS at room temperature for 1 h. The
cells were incubated with a 1:250 dilution of an anti-
HA rabbit polyclonal antibody (Novus Biologicals) for
2 h at room temperature, washed five times in PBS, in-
cubated 1 h with a 1:500 dilution of Alexa Fluor 594
goat anti-rabbit IgG (Molecular Probes), washed three
times in PBS then briefly in distilled water and mounted
with DAPI. Cells were analyzed using fluorescence mi-
croscopy. At least 100 cells were counted for each con-
struct. Cells were scored as “nuclear,” “nuclear and cy-
toplasmic,” or “cytoplasmic.”
Results and Discussion
Cohort Analysis
ZIC3 mutation analysis was performed by sequencing
in a cohort of 20 familial and 145 sporadic cases of
heterotaxy. Twenty-nine patients with atrial septal or
ventricular septal defects without evidence of a laterality
disorder were used as CHD controls. The 165 patients
with heterotaxy included 59 females and 106 males,
whereas the control CHD group consisted of 13 males
and 16 females. The ethnicity of the patients with
heterotaxy included 2% Asian ( ), 3% Africannp 3
American ( ), 42% white ( ), 32% Hispanicnp 5 np 69
( ), and 21% other or not determined ( ).np 53 np 35
Characteristics of the cohort are summarized in table
1. Patients with classic heterotaxy were subdivided on the
basis of spleen position and number. Asplenia and poly-
splenia are thought to represent bilateral right-sidedness
and bilateral left-sidedness, respectively; although they
have overlapping spectra of anatomic defects, each has
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Figure 4 Immunofluorescent subcellular localization of ZIC3. For each construct, anti-HA (panels A, D, G, J, and M) and DAPI (panels
B, E, H, K, and N) staining are shown individually and merged (panels C, F, I, L, and O). The wild-type construct is located in the nucleus
(panels A–C); the missense mutation construct P217A is primarily nuclear (panels D–F), whereas H286R is located in the cytoplasm (panels
G–I). T323M (panels J–L) and K408X (panels M–O) show evidence of cytoplasmic stippling.
also been associated with characteristic cardiovascular
malformations on the basis of autopsy series (Peoples et
al. 1983; Van Praagh et al. 1990; Phoon and Neill 1994;
Uemura et al. 1995). In our cohort, the asplenia pheno-
type is more commonly associated with total anomalous
pulmonary venous return and dextrocardia, whereas the
polysplenia phenotype is more commonly associated with
azygous continuation of the inferior vena cava and levo-
cardia. These findings are consistent with previously
published reports and indicate that this subpopulation
of our cohort reflects the commonly identified anatomic
abnormalities seen in heterotaxy. In general, the types
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Figure 5 Mutations in ZIC3 alter subcellular localization. The subcellular localization of anti-HA staining is shown graphically for each
construct. Nuclear, nuclear and cytoplasmic, and cytoplasmic staining are indicated as percentages.
Table 4
Summary of Mutation Analyses
Mutation
Inheritance, Sex, and
Clinical Phenotype
Reporter Gene
Transactivation
Subcellular
Localization
Mutation
Reference
S43X Fam; M; H D No protein detected Present study
P217A Spo; M; ASD, PS I Nuclear Present study
Q249X Fam; M; H D No protein detected Present study
C253S Fam; M; H D 80% nuclear Present study
C268X Fam; M; H D Cytoplasmic Gebbia et al. 1997
H286R Fam; M; H D Cytoplasmic Gebbia et al. 1997
Q292X Fam; M; H D Cytoplasmic Gebbia et al. 1997
T323M Fam; M; H D 45% nuclear Gebbia et al. 1997
1477–1478 ins TT Fam; M; H D 180% nuclear Gebbia et al. 1997
K405E Spo; F; isolated CHD D 80% nuclear Present study
K408X Fam; M; isolated CHD D 70% nuclear Megarbane et al. 2000
ASD p atrial septal defect; D p decreased; F p female; Fam p familial; H p classic heterotaxy; I p increased;
isolated CHD p congenital heart defect consistent with heterotaxy without other visceral anomalies; Mp male; PS
p pulmonic stenosis; Spo p sporadic.
of CCVM in the CHD heterotaxy group are similar, both
in complexity and anatomy, to those found in the classic
heterotaxy group. There is, however, an increased rep-
resentation of L-TGA and a decreased representation of
anomalous pulmonary venous return in the CHD het-
erotaxy group.
Identification of ZIC3 mutations
From a total of 194 patient samples, we identified 8
novel ZIC3 nucleotide changes: 2 nonsense mutations,
3 missense mutations, 2 silent nucleotide changes, and
1 nucleotide change in the 3′ untranslated region (table
2). The location of these novel point mutations, as well
as those previously reported (Gebbia et al. 1997; Megar-
bane et al. 2000), and their predicted effects in the ZIC3
amino acid sequence are shown in figure 1.
We ascertained three pedigrees with transmission of
heterotaxy consistent with X-linked inheritance. ZIC3
was sequenced in the probands (fig. 2), and two nonsense
mutations and one missense mutation were identified.
In each case, the mother of the proband was hetero-
zygous for the mutation. In pedigree LAT 138, a CrA
change results in a nonsense mutation and predicts pro-
tein truncation at amino acid 43. All previous mutations
have clustered in the zinc finger–binding domains (Geb-
bia et al. 1997; Megarbane et al. 2000); therefore, this
represents the most N-terminal mutation described to
date. A second nonsense mutation, located in a con-
served glutamine at amino acid 249, was found in ped-
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igree LAT 129. This mutation results in truncation prior
to the first zinc finger–binding domain.
The third familial mutation, C253S, is located at the
first residue of the first zinc finger. Several factors suggest
that this missense mutation is pathogenic. First, it is
found in the highly conserved cysteine that initiates the
first zinc finger domain and that forms one of the C2H2
zinc finger motifs. Second, this change was not found in
145 ethnically matched control chromosomes. Third, it
functions abnormally in transactivation and subcellular-
localization assays (see below). Figure 1 shows all cur-
rently identified ZIC3 mutations, including the five novel
mutations identified in the present study, and illustrates
the conservation of sequence across species found at the
missense mutation sites.
One ZIC3 mutation was identified in the cohort of
145 patients with sporadic heterotaxy (table 2). The mu-
tation, in exon 2, results in the substitution of glutamate
for lysine at amino acid 405. This residue is highly con-
served (fig. 1) and lies adjacent to a residue that partic-
ipates in the C2H2 motif at amino acid 406. This change
was not found in 145 ethnically matched control chro-
mosomes. It is notable that this is the first female with
CHD heterotaxy in whom a ZIC3 mutation has been
identified.
The second mutation identified in a patient with non-
heterotaxy CHD was from the group of 29 individuals
with nonheterotaxy CHD. The patient has an atrial sep-
tal defect and pulmonic stenosis (table 3). No other mal-
formation typically associated with heterotaxy was iden-
tified. The missense mutation at amino acid 217 results
in a substitution of alanine for proline. It is located out-
side the zinc finger domain in a residue that is incom-
pletely conserved among species (fig. 1). The results of
mutation analysis in sporadic cases therefore indicate
that ZIC3 mutations account for ∼1% (2/174; 95% CI
0.14%–4.0%) of this patient population. Furthermore,
our data indicate that ZIC3 mutations do not underlie
the male predominance seen in patients with heterotaxy.
Expansion of the Phenotypic Spectrum Associated
with ZIC3 Mutations
Table 3 summarizes the phenotypes of the three fa-
milial cases (LAT 107, LAT 129, and LAT 138) and the
two sporadic cases (LAT 818 and JT 15) in which ZIC3
mutations were identified. For each pedigree, the pro-
band is listed first, followed by other affected family
members for whom data were available. Although the
familial cases demonstrate anatomic anomalies very con-
sistent with findings in heterotaxy, they exhibit a number
of abnormalities not previously described in association
with ZIC3 mutations. Novel findings regarding cardiac
lesions include two cases of hypoplastic left heart and
two cases of total anomalous pulmonary venous return.
Novel extracardiac anomalies include omphalocele. Mid-
line defects are commonly associated with disorders of
laterality, most frequently affecting genitourinary or
musculoskeletal development (Gebbia et al. 1997; Ticho
et al. 2000). Genitourinary abnormalities, particularly
imperforate anus, have been consistently reported in
families with ZIC3 mutations (Casey et al. 1993; Gebbia
et al. 1997). In concordance with this, two of the families
identified in this study had affected members with im-
perforate anus. A variety of skeletal and renal defects
were noted as well. In addition, a number of features
not typically characteristic of heterotaxy syndromes, in-
cluding dysmorphic facial features, cystic hygroma, and
posterior embryotoxon were noted. It is interesting to
note that patient LAT 138 IV-2 carried a tentative di-
agnosis of Alagille syndrome and patient LAT 129 III-
6 was given a diagnosis of VATER association (MIM
192350). Because the clinical phenotype of patients with
ZIC3 mutations is broad, it should be considered in the
differential diagnosis of patients with multiple congen-
ital anomalies, particularly when CCVMs are involved.
It is surprising that the ZIC3 mutations that were
found in the subgroup of patients with sporadic CHD
were not in males with classic heterotaxy. Both individ-
uals had isolated heart defects without other manifes-
tations of heterotaxy, reinforcing a previous observation
that isolated congenital heart defects can result from
ZIC3 deficiency (Megarbane et al. 2000). Furthermore,
one of the patients was female, and the other patient
had a constellation of heart malformations not typi-
cally associated with CHD heterotaxy. The finding of
an affected female may reflect skewed X inactivation
within the proband. However, Zic3-deficient mice,
which closely mimic the anatomic abnormalities seen in
humans, show left-right patterning abnormalities in a
significant percentage (20%–40%) of heterozygous fe-
males (Purandare et al. 2002). Overall, these findings
confirm previous speculation that ZIC3 mutations may
be found both in females and in males and may be as-
sociated with isolated, nonheterotaxy CHD. They also
reinforce the need for an understanding of the molecular
determinants of looping cardiogenesis. Better under-
standing, in turn, may lead to a categorization of con-
genital heart defects more closely related to etiology and
may aid the evaluation of potential candidate genes.
Mutations in ZIC3 Alter Reporter Gene Transactivation
To test the functional significance of mutations in
ZIC3, site-directed mutagenesis was used to create pre-
viously published and newly identified mutations in the
context of the ZIC3 ORF (Gebbia et al. 1997; Megar-
bane et al. 2000). ZIC3 has been shown to be a weak
transcriptional activator and is hypothesized to act as a
transcriptional coactivator (Mizugishi et al. 2001). The
ZIC family physically and functionally interacts with
GLI proteins via the zinc finger–binding domains, but
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direct transcriptional targets of ZIC3 have not yet been
identified in vivo (Koyabu et al. 2001). In vitro, ZIC3
is able to activate a variety of target promoters, including
SV40. In HeLa cells, transfection of wild-type HA-
tagged ZIC3 demonstrated relatively strong transacti-
vation of an SV40 luciferase reporter, with levels ∼200-
fold higher than those of a promoterless control (data
not shown). We subsequently tested mutant constructs
containing nonsense, missense, or frameshift mutations
described in the present study and in others (Gebbia et
al. 1997; Megarbane et al. 2000). The results demon-
strate that ZIC3 mutations produce aberrant reporter
gene transactivation (fig. 3). Loss of activation occurs
both with mutations in the putative DNA-binding do-
main of the zinc finger region as well as with mutations
in the N-terminal domain. These results are consistent
with previous work in Xenopus, which demonstrated
that expression of the N-terminus of Zic3, in the absence
of the zinc finger–binding domain, causes left-right pat-
terning defects (Kitaguchi et al. 2000).
The nonsense mutations all show significant loss of
activation, including a 1477–1478insTT frameshift mu-
tation that results in a premature stop codon at amino
acid 408. All but one of the missense mutations also shows
a loss of transactivation. The exception is the N-terminal
mutation, P217A. In this case, a significant and repro-
ducible increase in transcriptional activation is noted. This
mutation was not found in 145 ethnicity-matched control
chromosomes or in 412 chromosomes within the CHD
cohort. It is of interest that the phenotype of this patient,
which consisted of an atrial septal defect and pulmonic
stenosis, is not characteristic of heterotaxy (table 3). It is
therefore interesting to speculate that activation of ZIC3
may contribute to additional phenotypic abnormalities
separable from classic heterotaxy. Zic1 has previously
been shown to play a role in the subcellular localization,
and thus posttranslational control, of Gli1 and Gli3 in a
cell-type–specific manner. Given the known physical in-
teraction between ZIC and GLI proteins, it is possible
that increases or decreases in ZIC3 expression alter the
stoichiometry of the GLI proteins at the cellular level.
Further mutation and functional analyses, both in vitro
and in vivo, will be required to establish whether acti-
vating mutations or overexpression of the ZIC3 tran-
scription factor plays a significant role in CHD.
Subcellular Localization
To further assess the functional significance of ZIC3
mutations, transient transfections were performed using
ZIC3-mutant constructs to determine subcellular local-
ization by use of immunofluorescence. Initially, the ap-
propriate expression pattern of ZIC3 and the effect of
epitope tagging were assessed using two constructs, an
N-terminal HA tagged ZIC3 and an N-terminal eGFP-
ZIC3 fusion. These constructs demonstrated nuclear lo-
calization of ZIC3 in both HeLa and P19 teratocarci-
noma cells (fig. 4 and data not shown), and HA-tagged
constructs were used for the remainder of the experi-
ments. It is interesting that all of the missense mutations
tested, with the exception of P217A, showed abnormal
subcellular localization (fig. 4 and data not shown). HA-
ZIC3 was detected in the cytoplasm or in both cytoplasm
and nucleus. In some cells, localization within the cy-
toplasm was in a stippled distribution. To compare the
relative distribution of ZIC3 by construct, 100–200 cells
were counted for each construct and were scored for
nuclear, nuclear and cytoplasmic, or cytoplasmic local-
ization. The results are shown in figure 5 and indicate
that loss of nuclear localization occurs for mutations
between amino acids 253 and 323. Nuclear-locali-
zation–prediction programs fail to identify a nuclear
localization sequence (NLS) for ZIC3. The lack of a
classical NLS suggests that ZIC3 may enter the nucleus
as a complex associated with other factors. Alternatively,
ZIC3 may contain a novel NLS or may enter the nucleus
directly via an unconventional pathway. The results ob-
tained using these known patient mutations delimit a
critical protein domain(s) required for nuclear locali-
zation. Furthermore, these results indicate that the path-
ogenesis of a subset of ZIC3 mutations results from
failure of the mutant protein to localize to the nucleus.
In addition to abnormalities in subcellular localiza-
tion, mutations also affected protein stability. Two trun-
cating mutations, S43X and Q249X, resulted in absent
or nearly absent protein (data not shown). Furthermore,
on the basis of the number of HA-expressing cells in this
assay, protein stability also appeared to be qualitatively
diminished with several of the missense mutations. A
summary of the mutations with their associated clinical
information and results of functional analyses is shown
in table 4.
In summary, our data demonstrate that ZIC3 muta-
tions account for ∼1% of sporadic CHD heterotaxy. The
additional mutations identified in the present study in-
dicate that mutations outside the zinc finger–binding do-
main can cause heterotaxy and further broaden the ge-
notypic and phenotypic spectrum of defects caused by
mutations in this gene. In addition, our data provide
methods for functional evaluation of ZIC3 mutations
and indicate that the pathogenesis of a subset of mu-
tations results from aberrant subcellular localization. Fu-
ture studies directed toward identifying the interactions
required for proper cellular localization should provide
valuable insight into the mechanisms by which ZIC3
functions in left-right patterning.
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